© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Irinotecan Hydrochloride Trihydrate stands as a vital raw material in the world of oncology and pharmaceutical science. This compound offers a lifeline for many dealing with colorectal and other cancers, shaping the standard of care for treatment strategies across hospitals and clinics. The molecular formula, C33H38N4O6·HCl·3H2O, speaks to its complex nature. The structure itself mirrors the intricate dance of atoms required to deliver a highly specific biochemical effect. Each molecule represents years of research and finely tuned synthetic chemistry, and the sheer precision involved in its creation underscores its price and significance within the pharmaceutical landscape.
This compound appears in a crystalline solid form. Sometimes it takes the form of yellowish flakes, or a pale powder, reflecting the variations that come during manufacturing and storage. Holding this compound, one can almost see the layers of science behind every granule. It doesn’t merely exist as a powder or a set of crystals—each physical format matters in clinical settings. Crystalline forms tend to flow differently when measured compared to amorphous powders. Handling and storage rely on these granular facts, as medical staff and researchers recognize the need for stable, clearly identifiable materials. Irinotecan Hydrochloride Trihydrate has a specific gravity (density) averaging around 1.43 g/cm³, laying a foundation for how it dissolves and mixes during compounding processes.
The molecular weight lies close to 677.2 g/mol, a figure signifying more than just mass. This weight impacts everything: dosing calculations, stability predictions, solubility assessments, and more. Chemically, the structure embodies a semi-synthetic camptothecin derivative, bearing a lactone ring crucial for its anti-tumor activity. This core structure reacts in predictable ways with water and solvents, so its presentation as a trihydrate means the presence of three water molecules per molecule, impacting its solubility and stability under typical storage conditions. Each version, whether powder, solid block, or granular flake, hints at the chemical care invested in its production.
Tracing the shipment and import of this chemical leads us to its HS Code: 2934999099. Pharmacies, research labs, and customs authorities rely on such codes to monitor movement, compliance, and safety. International trade does not run on handshakes—precise documentation ensures that pharmaceutical-grade materials reach their correct destination intact and unaltered. Every code stamped onto a shipping container tells its own story of safety inspections, transport protocols, and regulatory scrutiny.
Irinotecan Hydrochloride Trihydrate presents itself as a multi-faceted raw material. Solid at room temperature, it finds use as a fine powder or large, needle-like crystals depending on the batch and manufacturing approach. Bulk pharmaceutical chemicals do not serve a purely decorative function. Shape and form dictate how each batch enters solution, dissolves during preparation, and blends with solvents to create injectable formulas. Pharmacies depend on this flexibility. Powdered forms save time during compounding but can absorb atmospheric moisture if left exposed, creating storage challenges. Flakes often pack more tightly but demand careful measurement during weighing.
Dissolving Irinotecan Hydrochloride Trihydrate in sterile water forms a clear solution suitable for intravenous injection. The need for exact solubility and concentration levels drives pharmacists to measure, dilute, and mix with tremendous accuracy. With every batch, handling and preparation require personal protective equipment—gloves, masks, and laboratory coats. Chemists take these steps seriously, and with reason: this material bears a hazardous classification. Its harmful potential comes not just from accidental spillage but from airborne particulates during reconstitution, skin exposure, or accidental ingestion. My respect for meticulous laboratory protocols grows every time I see how professionals balance safety with urgency—not out of fear, but out of clear awareness of the risks involved.
This chemical doesn't sit quietly on a shelf, waiting for use—it demands respect. Classified as hazardous, Irinotecan Hydrochloride Trihydrate can cause acute health problems if mishandled. Inhalation of dust, skin absorption, and even indirect surface contact prompt real concern. Studies document adverse effects stemming from unintentional exposure: respiratory irritation, dermatitis, and—if accidental contact finds a route to the body—severe systemic toxicity. Storage vaults, fume hoods, and double-sealed containers don’t just lock up chemicals, they protect lives. The workspace reflects a communal commitment to safety, and that mindset forms the backbone of every reputable chemical supply chain.
Irinotecan Hydrochloride Trihydrate’s performance as a chemotherapy agent relies on its active structure. The lactone ring moiety gives it biological activity, engineered to interfere with DNA replication in cancer cells. The fine molecular differences between its crystalline, hydrated, and anhydrous forms can affect shelf life and clinical effectiveness. Every supplier emphasizes purity, so the industrial process avoids contamination from other synthesis byproducts. Consistency in molecular architecture isn’t an academic exercise; it ensures reproducible outcomes for patient care. That expectation shapes sourcing decisions for every pharmacy, research facility, and hospital.
Out in the field, workable solutions for safe handling center on education and practical measures. Routine training keeps staff alert to new protocols—as processes evolve, so does the response. Investing in better labeling, improved packaging, and electronic tracking enhances transparency, letting every handler trace a product’s journey from synthesis to administration. Manufacturers can invest more in robust data sheets, warning labels, and real-time digital safety alerts. For end users, simple but rigorous habits—washing hands, double-gloving, working with local exhaust ventilation—protect not just themselves, but patients and future batches. Reducing chemical accidents means fewer occupational health crises, less disruption in clinical operations, and more predictable access for patients relying on lifesaving treatments.
Working with Irinotecan Hydrochloride Trihydrate highlights a truth at the heart of chemical and clinical practice: attention to physical properties, structure, and safe handling saves lives. Anyone who has ever witnessed the preparation of a chemotherapy drug feels the gravity of the process. There are no shortcuts—only training, respect for detail, and chemistry with a purpose. This raw material earns respect not through mystery, but by the visible impact on patient outcomes whenever care teams treat not just the disease, but the science and safety behind each therapeutic advance.
